| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adenylate kinase 2 expression and addiction in T-ALL
|
Maslah, Nabih
|
|
|
5 |
3 |
p. 700-710
|
article
|
| 2 |
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project
|
Shustov, Andrei
|
|
|
5 |
3 |
p. 640-648
|
article
|
| 3 |
Allogeneic stem cell transplantation with omidubicel in sickle cell disease
|
Parikh, Suhag
|
|
|
5 |
3 |
p. 843-852
|
article
|
| 4 |
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
|
Cuker, Adam
|
|
|
5 |
3 |
p. 872-888
|
article
|
| 5 |
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax
|
Moses, Blake S.
|
|
|
5 |
3 |
p. 711-724
|
article
|
| 6 |
A patient with a germline GATA2 mutation and primary myelofibrosis
|
Rütsche, Cyrill V.
|
|
|
5 |
3 |
p. 791-795
|
article
|
| 7 |
A zebrafish model of granulin deficiency reveals essential roles in myeloid cell differentiation
|
Campbell, Clyde A.
|
|
|
5 |
3 |
p. 796-811
|
article
|
| 8 |
Constitutive activation of NF-κB during early bone marrow development results in loss of B cells at the pro-B-cell stage
|
Paun, Andrea
|
|
|
5 |
3 |
p. 745-755
|
article
|
| 9 |
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience
|
Maurer, Katie
|
|
|
5 |
3 |
p. 861-871
|
article
|
| 10 |
Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study
|
Terpos, Evangelos
|
|
|
5 |
3 |
p. 725-736
|
article
|
| 11 |
Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19
|
Guervilly, Christophe
|
|
|
5 |
3 |
p. 628-634
|
article
|
| 12 |
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19
|
Villa, Erica
|
|
|
5 |
3 |
p. 662-673
|
article
|
| 13 |
Editorial Board
|
|
|
|
5 |
3 |
p. i
|
article
|
| 14 |
Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma
|
Panayiotidis, Panayiotis
|
|
|
5 |
3 |
p. 823-828
|
article
|
| 15 |
Fibrin-modulating nanogels for treatment of disseminated intravascular coagulation
|
Mihalko, Emily P.
|
|
|
5 |
3 |
p. 613-627
|
article
|
| 16 |
Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets
|
Stratmann, Svea
|
|
|
5 |
3 |
p. 900-912
|
article
|
| 17 |
Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features
|
Zhou, Xiaolong Alan
|
|
|
5 |
3 |
p. 649-661
|
article
|
| 18 |
Impact of treatment delay in acute myeloid leukemia revisited
|
Juliusson, Gunnar
|
|
|
5 |
3 |
p. 787-790
|
article
|
| 19 |
JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells
|
Lawson, Hannah
|
|
|
5 |
3 |
p. 889-899
|
article
|
| 20 |
Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19
|
Jacobs, Chaja F.
|
|
|
5 |
3 |
p. 913-925
|
article
|
| 21 |
Loss of the exocyst complex component EXOC3 promotes hemostasis and accelerates arterial thrombosis
|
Walsh, Tony G.
|
|
|
5 |
3 |
p. 674-686
|
article
|
| 22 |
Low 5-year health care burden after umbilical cord blood transplantation
|
Garcia, Jesus Garcia
|
|
|
5 |
3 |
p. 853-860
|
article
|
| 23 |
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial
|
Simoes, Catia
|
|
|
5 |
3 |
p. 760-770
|
article
|
| 24 |
Molecular coevolution of coagulation factor VIII and von Willebrand factor
|
Zakas, Philip M.
|
|
|
5 |
3 |
p. 812-822
|
article
|
| 25 |
Pembrolizumab in mycosis fungoides with PD-L1 structural variants
|
Beygi, Sara
|
|
|
5 |
3 |
p. 771-774
|
article
|
| 26 |
Platelet reactivity to thrombin differs between patients with COVID-19 and those with ARDS unrelated to COVID-19
|
Zaid, Younes
|
|
|
5 |
3 |
p. 635-639
|
article
|
| 27 |
PML-controlled responses in severe congenital neutropenia with ELANE-misfolding mutations
|
Olofsen, Patricia A.
|
|
|
5 |
3 |
p. 775-786
|
article
|
| 28 |
Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation
|
Krutein, Michelle C.
|
|
|
5 |
3 |
p. 687-699
|
article
|
| 29 |
Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions
|
Waldis, Sarah J.
|
|
|
5 |
3 |
p. 737-744
|
article
|
| 30 |
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
|
von Meijenfeldt, Fien A.
|
|
|
5 |
3 |
p. 756-759
|
article
|
| 31 |
Unexpected redundancy of Gpr56 and Gpr97 during hematopoietic cell development and differentiation
|
Maglitto, Antonio
|
|
|
5 |
3 |
p. 829-842
|
article
|
Journal description